Nail products — including nail polishes, base coats, top coats, gel systems, acrylic nail systems, nail hardeners, cuticle treatments, and nail polish removers — are classified as cosmetic products under the FD&C Act and are subject to MoCRA facility registration, product listing, and safety substantiation requirements. The nail product category is one of the most technically diverse in cosmetics, spanning everything from simple lacquer formulations to UV-curable polymer systems, and the regulatory considerations vary significantly across product types. Foreign nail product manufacturers must understand which of their products are straightforward cosmetics, which may contain ingredients that require special attention, and which may cross the line into drug classification.
MoCRA requirements for nail products
Foreign facilities that manufacture nail products for the US market must register with the FDA under MoCRA. The registration requires a designated US Agent and must accurately identify the facility and its cosmetic product categories. The responsible person must list each nail product with the FDA, including the product's ingredient list. Safety substantiation must be maintained for each product and ingredient. Serious adverse events must be reported within 15 business days, and the product label must include contact information for adverse event reporting. These requirements apply equally to nail polish manufacturers, gel system producers, and acrylic nail powder suppliers.
Ingredient safety concerns in nail products
Nail products have historically contained several ingredients that have raised safety concerns. The 'toxic trio' — toluene, dibutyl phthalate (DBP), and formaldehyde — has been the subject of consumer advocacy and regulatory attention for years. Toluene is used as a solvent in many nail polish formulations. DBP is used as a plasticizer. Formaldehyde is used as a nail hardening agent and also appears as a preservative. While none of these ingredients are currently banned by the FDA for use in nail products, many brands have reformulated to exclude them in response to consumer demand and state-level regulations. California Proposition 65, for example, lists formaldehyde as a known carcinogen, and products containing formaldehyde sold in California must carry a warning statement.
Methyl methacrylate (MMA) is another ingredient of concern. Liquid MMA was widely used in artificial nail systems but has been the subject of FDA advisory opinions due to injury reports, including severe nail damage and allergic reactions. While the FDA has not formally banned MMA in nail products, many states have prohibited its use in nail salons, and the professional nail industry has largely shifted to ethyl methacrylate (EMA) as a safer alternative. Foreign manufacturers of acrylic nail systems should verify whether their formulations contain MMA and understand the regulatory and market implications.
Nail treatments that cross into drug territory
Nail products that make claims beyond cosmetic appearance alteration may be classified as drugs. A nail hardener that claims to 'strengthen nails' by altering the nail structure may be considered a drug. A cuticle treatment that claims to 'heal damaged cuticles' makes a therapeutic claim that triggers drug classification. An antifungal nail treatment is unquestionably a drug. Foreign manufacturers should review all claims on their nail product labels and marketing materials to ensure that no claim crosses the cosmetic-to-drug boundary. Products that make drug claims must be registered as OTC drug products, must carry Drug Facts labeling, and must comply with applicable OTC monographs or hold approved NDAs.
Color additives in nail products
Nail polishes use a wide range of color additives, and all colors must be FDA-authorized for cosmetic use. Many nail polish colorants are D&C colors that require batch certification by the FDA. Certain pigments commonly used in nail polishes — such as various D&C Red and D&C Orange shades — have use restrictions that limit them to externally applied cosmetics only, which is acceptable for nail products but would not be appropriate for lip or eye products from the same manufacturer. Glitter and metallic effects in nail products may involve color additives, plastic glitters, or metallic flakes, each of which must comply with applicable FDA regulations.
How FDABridge helps nail product manufacturers
FDABridge provides MoCRA facility registration, product listing, and compliance guidance for foreign nail product manufacturers. We help ensure your products are correctly classified, your ingredients are FDA-compliant, and your labels meet US requirements. Visit fdabridge.com/cosmetics to see our cosmetics services or fdabridge.com/contact to discuss your nail product compliance needs.
Need help with MoCRA filings?
See our cosmetics services for facility registration, product listing, and label review support.